BioVersys raises CHF 2.5 millions in a Seed Financing round

VISCHER Ltd advises the investors in the seed financing round of CHF 2.5 million of BioVersys. With this, BioVersys has taken the first step towards the development of novel therapies to overcome bacterial resistance against antibiotics. The team at VISCHER AG is led by Matthias Staehelin (Partner) with Martina Strub (Associate).

Matthias Staehelin

Attorney at Law and Civil Law Notary (BS/BL)

• Partner

• +41 58 211 33 53
• [email protected]